TR199900504T2 - Osteoporoz dahil olmak �zere menopoz sonras� hastal�klar�n tedavi y�ntemi - Google Patents

Osteoporoz dahil olmak �zere menopoz sonras� hastal�klar�n tedavi y�ntemi

Info

Publication number: TR199900504T2
Authority: TR; Turkey
Prior art keywords: treatment method; including osteoporosis; postmenopausal; diseases; postmenopausal diseases
Prior art date: 1996-09-06

Application number

TR1999/00504T

Other languages

English (en)

Turkish (tr)

Inventor

N. Bradbeer Jeremy

Gowen Maxine

Original Assignee

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-06

Filing date

1997-09-03

Publication date

1999-06-21

1997-09-03 Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation

1999-06-21 Publication of TR199900504T2 publication Critical patent/TR199900504T2/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyrrole Compounds (AREA)
Saccharide Compounds (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

TR1999/00504T 1996-09-06 1997-09-03 Osteoporoz dahil olmak �zere menopoz sonras� hastal�klar�n tedavi y�ntemi TR199900504T2 (xx)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2543996P	1996-09-06	1996-09-06
US5066697P	1997-06-24	1997-06-24

Publications (1)

Publication Number	Publication Date
TR199900504T2 true TR199900504T2 (xx)	1999-06-21

Family

ID=26699738

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
TR1999/00506T TR199900506T2 (xx)	1996-09-06	1997-09-03	Yeni y�ntemler.
TR1999/00504T TR199900504T2 (xx)	1996-09-06	1997-09-03	Osteoporoz dahil olmak �zere menopoz sonras� hastal�klar�n tedavi y�ntemi

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
TR1999/00506T TR199900506T2 (xx)	1996-09-06	1997-09-03	Yeni y�ntemler.

Country Status (16)

Country	Link
EP (2)	EP0929216A4 (xx)
JP (2)	JP2002515047A (xx)
KR (2)	KR20000068472A (xx)
CN (2)	CN1236299A (xx)
AR (1)	AR008155A1 (xx)
AU (2)	AU4247397A (xx)
BR (2)	BR9711681A (xx)
CA (2)	CA2264943A1 (xx)
CO (2)	CO5070658A1 (xx)
CZ (1)	CZ76699A3 (xx)
IL (1)	IL128645A0 (xx)
NO (2)	NO991096D0 (xx)
PL (2)	PL332038A1 (xx)
TR (2)	TR199900506T2 (xx)
TW (1)	TW411273B (xx)
WO (2)	WO1998009519A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998034608A1 (en) *	1997-02-11	1998-08-13	Novo Nordisk A/S	Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) *	1998-12-09	1999-02-03	Orion Corp	Agent for lowering endothelin levels
DE19905961A1 (de) *	1999-02-12	2000-08-17	Stefan Neubauer	Verwendung von Östrogenen zur Behandlung der Herzinsuffizienz
US6528681B2 (en) *	2000-04-05	2003-03-04	Bristol-Meyers Squibb Pharma Company	Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
IL145876A0 (en)	2000-10-17	2002-07-25	Pfizer Prod Inc	Methods and kits for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2196003A (en) *	1986-09-11	1988-04-20	Nat Res Dev	Iodo-and bromo-tamoxifen derivatives
DK0660821T3 (da) *	1992-09-15	1998-09-21	Merrell Pharma Inc	Ikke-metaboliserbare clomiphen-analoge til behandling af tamoxifen-resistente tumorer
US5681835A (en) *	1994-04-25	1997-10-28	Glaxo Wellcome Inc.	Non-steroidal ligands for the estrogen receptor
US5604248A (en) *	1994-05-05	1997-02-18	Eli Lilly And Company	Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) *	1994-05-23	1995-11-28	Stromberg; Brent V.	Method of treating peripheral vasoconstriction with tamoxifen citrate
AU6277396A (en) *	1995-06-07	1996-12-30	Neorx Corporation	Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
HN1996000101A (es) *	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis
US6069175A (en) *	1996-11-15	2000-05-30	Pfizer Inc.	Estrogen agonist/antagonists treatment of atherosclerosis

1997
- 1997-08-29 AR ARP970103968A patent/AR008155A1/es unknown
- 1997-09-03 AU AU42473/97A patent/AU4247397A/en not_active Abandoned
- 1997-09-03 BR BR9711681A patent/BR9711681A/pt not_active Application Discontinuation
- 1997-09-03 EP EP97940773A patent/EP0929216A4/en not_active Withdrawn
- 1997-09-03 PL PL97332038A patent/PL332038A1/xx unknown
- 1997-09-03 WO PCT/US1997/015474 patent/WO1998009519A1/en not_active Ceased
- 1997-09-03 WO PCT/US1997/015475 patent/WO1998009619A1/en not_active Ceased
- 1997-09-03 CA CA002264943A patent/CA2264943A1/en not_active Abandoned
- 1997-09-03 PL PL97332278A patent/PL332278A1/xx unknown
- 1997-09-03 KR KR1019997001860A patent/KR20000068472A/ko not_active Withdrawn
- 1997-09-03 TR TR1999/00506T patent/TR199900506T2/xx unknown
- 1997-09-03 CA CA002264775A patent/CA2264775A1/en not_active Abandoned
- 1997-09-03 TR TR1999/00504T patent/TR199900504T2/xx unknown
- 1997-09-03 CZ CZ99766A patent/CZ76699A3/cs unknown
- 1997-09-03 IL IL12864597A patent/IL128645A0/xx unknown
- 1997-09-03 JP JP51283898A patent/JP2002515047A/ja active Pending
- 1997-09-03 JP JP51283798A patent/JP2002515046A/ja active Pending
- 1997-09-03 EP EP97942388A patent/EP0927029A4/en not_active Withdrawn
- 1997-09-03 BR BR9711676A patent/BR9711676A/pt not_active Application Discontinuation
- 1997-09-03 KR KR1019997001861A patent/KR20000068473A/ko not_active Withdrawn
- 1997-09-03 CN CN97199492A patent/CN1236299A/zh active Pending
- 1997-09-03 CN CN97199493A patent/CN1236313A/zh active Pending
- 1997-09-03 AU AU44097/97A patent/AU4409797A/en not_active Abandoned
- 1997-09-04 CO CO97051289A patent/CO5070658A1/es unknown
- 1997-09-04 CO CO97051287A patent/CO4920218A1/es unknown
- 1997-12-11 TW TW086112930A patent/TW411273B/zh active
1999
- 1999-03-05 NO NO991096A patent/NO991096D0/no not_active Application Discontinuation
- 1999-03-05 NO NO991097A patent/NO991097D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU4409797A (en)	1998-03-26
BR9711681A (pt)	1999-08-24
EP0929216A1 (en)	1999-07-21
CO5070658A1 (es)	2001-08-28
AU4247397A (en)	1998-03-26
WO1998009619A1 (en)	1998-03-12
WO1998009519A1 (en)	1998-03-12
CZ76699A3 (cs)	1999-08-11
IL128645A0 (en)	2000-01-31
PL332038A1 (en)	1999-08-16
AR008155A1 (es)	1999-12-09
CN1236299A (zh)	1999-11-24
EP0929216A4 (en)	2001-04-04
NO991097L (no)	1999-03-05
EP0927029A4 (en)	2001-06-13
JP2002515046A (ja)	2002-05-21
NO991096L (no)	1999-03-05
CA2264943A1 (en)	1998-03-12
TW411273B (en)	2000-11-11
BR9711676A (pt)	1999-08-24
CA2264775A1 (en)	1998-03-12
NO991096D0 (no)	1999-03-05
KR20000068473A (ko)	2000-11-25
CN1236313A (zh)	1999-11-24
EP0927029A1 (en)	1999-07-07
KR20000068472A (ko)	2000-11-25
CO4920218A1 (es)	2000-05-29
JP2002515047A (ja)	2002-05-21
TR199900506T2 (xx)	1999-07-21
NO991097D0 (no)	1999-03-05
PL332278A1 (en)	1999-08-30

Publication	Publication Date	Title
TR199600096A2 (tr)	1996-08-21	Yeni bilesikler.
TR199501655A2 (tr)	1996-07-21	Yeni monosiklik -laktam bilesikleri.
TR199501597A2 (tr)	1996-07-21	Yeni bilesikler.
ATE291430T1 (de)	2005-04-15	Behandlung postklimakterischer frauen unter verwendung niedrigster estrogendosen
TR199700092A2 (tr)	1997-08-21	Yeni, sübstitüe edilmis oksazolidinonlar.
DE69602638D1 (de)	1999-07-08	Naphthylverbindungen, Zwischenprodukte, Zusammensetzungen und Methoden
NO983002L (no)	1998-08-26	Vitronectin-reseptor-antagonister
ES2179273T3 (es)	2003-01-16	N-bencil-2-fenilindolas como agentes estrogenicos.
ES529370A0 (es)	1985-09-01	Un procedimiento para la preparacion de 3-(4-piperidil)-1, 2-bencisoxazoles
DK1438957T3 (da)	2007-07-30	Raloxifen til behandling af postmenopausal osteoporose
MD1745B2 (en)	2001-09-30	4,5-dimethyl-N-2-propenyl-2-(trimethylsilyl)-3-thiophencarboxamide, fungicidal composition on base thereof and method of plants diseases control
FI962445A7 (fi)	1996-06-12	Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
FI874660A7 (fi)	1988-04-25	Aine hammasjäljennöksiä varten.
AR016981A2 (es)	2001-08-01	Polipeptidos sinteticos
DK0817851T5 (da)	2004-10-25	DNA, der koder for humant papillomvirus type 18
BR9509741A (pt)	1997-10-21	Composto e uso de composto
DE69005172D1 (de)	1994-01-27	Zahnzemente.
ATE181737T1 (de)	1999-07-15	Cck oder gastrin modulierende 5-heterocyclicyl- 1,5-benzodiazepine
TR199900504T2 (xx)	1999-06-21	Osteoporoz dahil olmak �zere menopoz sonras� hastal�klar�n tedavi y�ntemi
NO986086D0 (no)	1998-12-23	FremgangsmÕte for fremstilling av 17-estere av 9<alfa>,21-dihalo-pregnan-11
DE69736180D1 (de)	2006-08-03	Behandlung von manischen erkrankungen
SE9700706D0 (sv)	1997-02-27	Process for the preparation of benzothiazoline compounds
DE69507628D1 (de)	1999-03-11	Steuereinrichtung zur optimalen benutzung der energie, die durch die schiffshauptenergiequelle erzeugt wird
SE9602416D0 (sv)	1996-06-18	New forms of an organic salt of N'N-diacetylcystine
DE59004528D1 (de)	1994-03-17	Verwendung des (+)-enantiomeren von anipamil.